Latest news with #Investing
Yahoo
2 hours ago
- Business
- Yahoo
Zacks Investment Ideas feature highlights: SPDR Gold Shares ETF, Agnico Eagle Mines, Kinross Gold, AngloGold Ashanti and Aris Mining
For Immediate Release Chicago, IL – July 22, 2025 – Today, Zacks Investment Ideas feature highlights SPDR Gold Shares ETF GLD, Agnico Eagle Mines AEM, Kinross Gold KGC, AngloGold Ashanti PLC AU and Aris Mining Corp. ARMN. The Ascent of Gold Stocks: Why Investors Can Buy Now Gold continues to shine in 2025, outperforming the S&P 500 over the past 1-year, 3-year, and year-to-date periods. Amid dramatic geopolitical shifts, rising global uncertainty, and persistent concerns over fiat currency stability, demand for gold remains strong, and there's little reason to expect that trend to reverse anytime soon. Invest in Gold Priority Gold: Up to $15k in Free Silver + Zero Account Fees on Qualifying Purchase American Hartford Gold: #1 Precious Metals Dealer in the Nation Thor Metals Group: Best Overall Gold IRA From a technical standpoint, an especially compelling setup is forming in the gold market, with price action coiling just beneath key resistance levels. Gold prices are rallying aggressively today and appear as if they are about to break out from this technical pattern. Not surprisingly, several top gold mining stocks are also performing extremely well. While some investors may choose to gain exposure through the SPDR Gold Shares ETF, individual miners like Agnico Eagle Mines, Kinross Gold, AngloGold Ashanti PLC and Aris Mining Corp. offer even greater upside. All four stocks carry a Zacks Rank #1 (Strong Buy) rating, signaling strong earnings revisions, and each displays impressive price momentum and relative strength. In the sections below, we'll explore the current technical setup in gold, break down why this rally has staying power, and highlight the top-ranked stocks best positioned to benefit. Gold on the Verge of a Massive Breakout Gold has been one of the most resilient assets in recent years, and it may now be setting up for another major move higher. The drivers of gold's ascent have been both structural and cyclical, most notably, a surge in central bank demand as BRICS nations and other emerging markets seek to diversify away from US dollar-denominated assets. This de-dollarization trend has led to record levels of gold accumulation by sovereign entities. Layered on top of that is rising macro and geopolitical uncertainty. The return of Donald Trump to the political spotlight has injected renewed volatility into the policy outlook, particularly around trade, global alliances, and the Federal Reserve. Meanwhile, inflation remains somewhat unpredictable. In that context, gold has remained firmly bid as a hedge against policy missteps and monetary disorder. Geopolitical catalysts continue to add fuel to the fire including the Russia–Ukraine war, tensions between the US and China, especially over Taiwan and semiconductor supply chains. And instability in the Middle East continues to flare unpredictably These global dynamics, combined with gold's growing recognition as a valuable portfolio diversifier, have continued to bring new marginal buyers into the market, including both institutions and high-net-worth individuals looking to hedge against systemic risk. Technically, gold has been building out a tightening bull flag pattern over the past three months. There's been a strong buyer on the bid this Monday, and a decisive break above $317.50 on GLD (or $3,475 in gold futures) would likely signal a technical breakout, opening the door for the next major leg higher. Aris Mining Corporation: A Compelling Gold Stock Opportunity Among the group of top-performing gold stocks, Aris Mining Corporation stands out as a particularly compelling opportunity, despite being the smallest by market cap at just $1.25 billion. From a fundamental standpoint, Aris offers a rare combination of value and growth. The stock trades at just 5.8x forward earnings, well below the industry average, yet has impressive revenue and earnings growth forecasts. Sales are expected to rise 56% this year, followed by another 74% increase next year. Even more impressively, earnings are projected to surge 265% this year and another 74% in 2026. That explosive growth has not gone unnoticed by traders. The stock has delivered over 100% year-to-date returns, exhibiting strong price momentum and relative strength against both the market and its peers. With gold prices pressing toward a breakout and capital rotating into miners, Aris Mining could be just getting started. For investors looking for asymmetric upside in a smaller-cap gold play, Aris offers a compelling blend of momentum, earnings power, and undervaluation. Agnico Eagle Mines: Stock Testing Breakout Level Agnico Eagle Mines is one of the most established and well-managed gold producers in the world and it continues to deliver both operational consistency and long-term growth. The stock currently holds a Zacks Rank #1 (Strong Buy), reflecting positive earnings estimate revisions and strong institutional support. AEM offers a favorable mix of reasonable valuation and solid long-term growth potential. The stock trades at just 17.9x forward earnings, while Analysts project annual EPS growth of 20.8% over the next three to five years, an impressive trajectory for a company of its size and maturity. Technically, AEM has been consolidating in a bullish flag pattern, closely mirroring the recent price action in gold itself. The stock is currently coiling just below the $124 resistance level, and a decisive move above that price would signal a technical breakout, potentially ushering in a new leg higher. Kinross Gold: Shares Trade at a Discount to Growth Kinross Gold is a well-established mid-tier gold producer with a diversified global asset base and a strong track record of operational performance. The stock currently holds a Zacks Rank #1 (Strong Buy). Over the past two months, earnings estimates have been revised sharply higher, with FY25 projections rising 11% and FY26 estimates climbing 16.5%. These revisions underscore growing optimism around Kinross's production outlook and profitability as gold prices remain elevated. Valuation-wise, KGC trades at just 12.7x forward earnings, offering a significant discount to its earnings growth. With EPS expected to grow at an average annual rate of 21.2% over the next three to five years, the stock boasts a PEG ratio of just 0.6, signaling a compelling growth-at-a-reasonable-price (GARP) opportunity. AngloGold Ashanti PLC: Stock Boasts Powerful Momentum AngloGold Ashanti is a leading global gold producer with a diversified portfolio of assets across Africa, the Americas, and Australia. The company has long been known for its operational scale and strong reserve base, but it's the recent price action that has captured investor attention. Currently holding a Zacks Rank #1 (Strong Buy), AngloGold has seen renewed interest from institutional and momentum-driven investors in 2024. The stock has delivered the strongest year-to-date performance among its peers, surging over 120% as of mid-July. This explosive rally reflects both rising gold prices and investor confidence in AU's production outlook and cost management. From a technical standpoint, AU has exhibited exceptional relative strength, consistently outperforming the broader market and gold mining sector throughout the year. The stock remains in a well-defined uptrend, with buying pressure accelerating on every dip, a classic sign of institutional accumulation. Should Investors Buy Shares in Gold and Gold Mining Stocks? With gold prices approaching a major technical breakout and global demand supported by powerful macro trends, the outlook for gold remains highly constructive. Whether you're seeking a hedge against uncertainty or exposure to a rising commodity trend, gold stocks offer an attractive entry point today. For investors seeking asymmetric upside and diversification, now may be an opportune time to add gold and gold equities to your portfolio. Research Chief Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months. Free: See Our Top Stock And 4 Runners Up Media Contact Zacks Investment Research 800-767-3771 ext. 9339 support@ Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Kinross Gold Corporation (KGC) : Free Stock Analysis Report AngloGold Ashanti PLC (AU) : Free Stock Analysis Report Agnico Eagle Mines Limited (AEM) : Free Stock Analysis Report SPDR Gold Shares (GLD): ETF Research Reports Aris Mining Corporation (ARMN) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
&w=3840&q=100)
Business Standard
4 hours ago
- Business
- Business Standard
H.I.T. Investing: A new book the balance between purpose and profit
It is hard to fathom how any organisation could build a sustainable business by offering high-quality products at affordable prices, but many have done just that. H.I.T. Investing tells their stories Sanjay Kumar Singh Mumbai Listen to This Article H.I.T. Investing: Strong returns through high-impact investing leveraging technology Published by Penguin Business 214 pages ₹799 Can investment firms achieve social or environmental impact while generating sound financial returns? Author Mahesh Joshi answers in the affirmative in his book H.I.T. Investing, which explores the principles and practice of impact investing. This approach seeks to improve the world while earning competitive returns. The global impact investing industry is currently valued at $2.3 trillion. Impact investors begin by identifying causes that matter to them, then back early-stage companies aligned with those goals, typically in sectors such as microfinance, health, education and so on.
Associated Press
7 hours ago
- Business
- Associated Press
Income Calendar Dividend Tracker Service Surpasses $1B Linked Assets
Our popular Dividend Tracker service, Income Calendar, has surpassed $1 Billion in linked assets. JERICHO, NY / ACCESS Newswire / July 23, 2025 / BNK Invest Inc. today announces that our popular Dividend Tracker service, Income Calendar, has surpassed $1 Billion in linked assets. 'The simplicity of linking brokerage accounts to our popular Income Calendar tool continues to gain traction, with over $1 billion of assets now linked,' said the company's Chief Operating Officer. Popular Income Calendar features include: Learn more about the service, watch our Demo Video, or sign up for your risk-free trial period, by visiting About BNK Invest, Inc. & Contrarian Outlook A service of online media company BNK Invest Inc., Contrarian Outlook is home to Contrarian Income Report, employing second level thinking to hunt down safe, stable, meaningful yields through a calculated contrarian strategy. Our Hidden Yields service taps into the incredible profit potential of income loopholes that are 'invisible' to 99% of investors. Learn more about these and other premium newsletters by clicking here or going to BNK provides a number of other investment research and news websites to the public, aimed at empowering investors to better research individual stocks and strategies. Learn more at and Contact Information: [email protected] SOURCE: BNK Invest, Inc. press release
Globe and Mail
8 hours ago
- Business
- Globe and Mail
Deutsche Bank Reaffirms Their Sell Rating on Roche Holding AG (RHHVF)
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Sell rating on Roche Holding AG, with a price target of CHF235.00. The company's shares closed yesterday at $321.46. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Papadakis is a 4-star analyst with an average return of 3.5% and a 51.43% success rate. Papadakis covers the Healthcare sector, focusing on stocks such as Novo Nordisk, Novartis AG, and AstraZeneca. In addition to Deutsche Bank , Roche Holding AG also received a Sell from J.P. Morgan's Richard Vosser in a report issued yesterday. However, on July 17, Berenberg Bank maintained a Hold rating on Roche Holding AG (Other OTC: RHHVF). The company has a one-year high of $354.19 and a one-year low of $269.80. Currently, Roche Holding AG has an average volume of 11.61K.
Globe and Mail
14 hours ago
- Business
- Globe and Mail
Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT), Veeva Systems (VEEV) and Elevance Health (ELV)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sarepta Therapeutics (SRPT – Research Report), Veeva Systems (VEEV – Research Report) and Elevance Health (ELV – Research Report). Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Sarepta Therapeutics (SRPT) Sarepta Therapeutics received a Hold rating and a $18.00 price target from Barclays analyst Gena Wang today. The company's shares closed last Monday at $13.32. According to Wang is a 3-star analyst with an average return of 2.8% and a 42.4% success rate. Wang covers the Healthcare sector, focusing on stocks such as Ultragenyx Pharmaceutical, 4D Molecular Therapeutics, and BioMarin Pharmaceutical. ;'> The word on The Street in general, suggests a Hold analyst consensus rating for Sarepta Therapeutics with a $30.82 average price target, which is a 140.5% upside from current levels. In a report issued on July 18, Needham also downgraded the stock to Hold with a $50.00 price target. Veeva Systems (VEEV) In a report released today, Saket Kalia from Barclays maintained a Buy rating on Veeva Systems, with a price target of $300.00. The company's shares closed last Monday at $281.00. According to Kalia is a 5-star analyst with an average return of 16.5% and a 64.2% success rate. Kalia covers the Technology sector, focusing on stocks such as CCC Intelligent Solutions Holdings, Procore Technologies, and CrowdStrike Holdings. ;'> The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Veeva Systems with a $295.52 average price target, which is a 4.5% upside from current levels. In a report issued on July 14, Wells Fargo also maintained a Buy rating on the stock with a $300.00 price target. Elevance Health (ELV) Barclays analyst Andrew Mok CFA maintained a Buy rating on Elevance Health today and set a price target of $327.00. The company's shares closed last Monday at $276.45. According to CFA is ranked 0 out of 5 stars with an average return of -8.4% and a 41.1% success rate. CFA covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Brookdale Senior Living, and Alignment Healthcare. ;'> Currently, the analyst consensus on Elevance Health is a Strong Buy with an average price target of $380.47, a 36.7% upside from current levels. In a report issued on July 8, Bernstein also maintained a Buy rating on the stock with a $585.00 price target.
